Gastrointestinal Toleration of Inulin Products

February 9, 2017 updated by: University of Minnesota

Effect of Two Doses of Inulin Products on Gastrointestinal Tolerance

The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products.

The investigators hypothesis that doses of up to 10 grams of inulin products should be well tolerated and not result in a significant increase in gastrointestinal symptoms.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

0, 5, and 10 grams of inulin

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Minneapolis, Minnesota, United States, 55108
        • University of Minnesota: Nutrition and Food Science Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • english speaking
  • healthy men and women
  • 18 and 60 years of age
  • non-smoking
  • non-dieting
  • BMI less than 30
  • standard diet consisting of no more than 15 grams fiber
  • not taking medications

Exclusion Criteria:

  • BMI more than 30
  • CVD
  • Diabetes Mellitus
  • cancer in prior 5 years
  • renal or hepatic disease
  • bacterial infection in past 2 weeks
  • more than 5 kg weight loss in past 3 months
  • history of drug or alcohol abuse in past 6 months
  • use of weight loss, lipid-lowering, anti-hypertensive, or anti- inflammatory medications
  • concurrent or recent intervention study participation
  • consumption of laxatives
  • history of gastrointestinal disorders
  • food allergies
  • pregnant or lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: inulin
0, 5, 10 g inulin
Dietary supplement: Inulin Fiber Supplement
Orange juice fortified with 0, 5g, and 10g of 2 inulin products

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Gastrointestinal Tolerance Score
Time Frame: Aug 2008 thru Oct 2008
Aug 2008 thru Oct 2008

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Minnesota

Collaborators

Cargill

Investigators

  • Principal Investigator: Joanne L Slavin, PhD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

October 1, 2008

Study Completion (Actual)

October 1, 2008

Study Registration Dates

First Submitted

August 12, 2009

First Submitted That Met QC Criteria

August 12, 2009

First Posted (Estimate)

August 13, 2009

Study Record Updates

Last Update Posted (Actual)

February 10, 2017

Last Update Submitted That Met QC Criteria

February 9, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 0805M32121

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Inulin Fiber Supplement

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe